Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Principles of psychopharmacology for mental health professionals [[electronic resource] /] / Jeffrey E. Kelsey, D. Jeffrey Newport, Charles B. Nemeroff
| Principles of psychopharmacology for mental health professionals [[electronic resource] /] / Jeffrey E. Kelsey, D. Jeffrey Newport, Charles B. Nemeroff |
| Autore | Kelsey Jeffrey E |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Liss, c2006 |
| Descrizione fisica | 1 online resource (411 p.) |
| Disciplina |
615.78
615/.78 |
| Altri autori (Persone) |
NewportD. Jeffrey
NemeroffCharles B |
| Soggetto topico |
Mental illness - Chemotherapy
Psychopharmacology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-51752-2
9786610517527 0-470-30737-4 0-471-79463-5 0-471-79462-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
PRINCIPLES OF PSYCHOPHARMACOLOGY FOR MENTAL HEALTH PROFESSIONALS; CONTENTS; Preface; Faculty Disclosure; 1 INTRODUCTION AND OVERVIEW; Additional Reading; 2 BASICS OF PSYCHOPHARMACOLOGY; 2.1 Introduction; 2.1.1 Learning the Language of Pharmacology; 2.1.2 Overview; 2.2 Normal Human Nervous System; 2.2.1 Neuroanatomy: Structure of the Nervous System; 2.2.2 Neurophysiology: Function of the Nervous System; 2.3 Pathophysiology: Study of What Goes Wrong; 2.3.1 What Goes Wrong; 2.3.2 Why It Goes Wrong; 2.4 Pharmacology; 2.4.1 Introduction; 2.4.2 Pharmacokinetics; 2.4.3 Pharmacodynamics
2.4.4 Predicting Medication Effects2.4.5 Predicting Drug Interactions; 2.5 Putting It All Together; Additional Reading; 3 MOOD DISORDERS; 3.1 Introduction; 3.2 Major Depressive Disorder; 3.2.1 Brief Description and Diagnostic Criteria; 3.2.2 Prevalence and Risk Factors; 3.2.3 Presentation and Clinical Course; 3.2.4 Initial Evaluation and Differential Diagnosis; 3.2.5 History of Pharmacological Treatment; 3.2.6 Current Approach to Treatment; 3.2.7 Refractory Depression; 3.3 Dysthymic Disorder; 3.3.1 Brief Description and Diagnostic Criteria; 3.3.2 Prevalence and Risk Factors 3.3.3 Presentation and Clinical Course3.3.4 Initial Evaluation and Differential Diagnosis; 3.3.5 History of Pharmacological Treatment; 3.3.6 Current Approach to Treatment; 3.3.7 Refractory Depression; 3.4 Bipolar Disorders; 3.4.1 Brief Description and Diagnostic Criteria; 3.4.2 Prevalence and Risk Factors; 3.4.3 Presentation and Clinical Course; 3.4.4 Initial Evaluation and Differential Diagnosis; 3.4.5 History of Pharmacological Treatment; 3.4.6 Current Approach to Treatment; Additional Reading; 4 SCHIZOPHRENIA; 4.1 Brief Description and Diagnostic Criteria; 4.2 Prevalence and Risk Factors 4.3 Presentation and Clinical Course4.4 Initial Evaluation and Differential Diagnosis; 4.5 History of Treatment; 4.6 Current Approach to Treatment; 4.6.1 Prodromal Phase; 4.6.2 Acute Phase; 4.6.3 Maintenance Phase; 4.6.4 Residual Phase; 4.7 Treatment Resistant Schizophrenia; Additional Reading; 5 ANXIETY DISORDERS; 5.1 Introduction; 5.1.1 History of Anxiety Disorders; 5.1.2 Anxiety Symptoms; 5.1.3 Brief Overview of the Anxiety Disorders; 5.1.4 History of Pharmacological Treatment for Anxiety; 5.2 Panic Disorder; 5.2.1 Brief Description and Diagnostic Criteria 5.2.2 Prevalence and Risk Factors5.2.3 Presentation and Clinical Course; 5.2.4 Initial Evaluation and Differential Diagnosis; 5.2.5 History of Pharmacological Treatment; 5.2.6 Current Approach to Treatment; 5.3 Generalized Anxiety Disorder; 5.3.1 Brief Description and Diagnostic Criteria; 5.3.2 Prevalence and Risk Factors; 5.3.3 Presentation and Clinical Course; 5.3.4 Initial Evaluation and Differential Diagnosis; 5.3.5 History of Pharmacological Treatment; 5.3.6 Current Approach of Treatment; 5.4 Obsessive-Compulsive Disorder; 5.4.1 Brief Description and Diagnostic Criteria 5.4.2 Prevalence and Risk Factors |
| Record Nr. | UNINA-9910143568403321 |
Kelsey Jeffrey E
|
||
| Hoboken, N.J., : Wiley-Liss, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Principles of psychopharmacology for mental health professionals [[electronic resource] /] / Jeffrey E. Kelsey, D. Jeffrey Newport, Charles B. Nemeroff
| Principles of psychopharmacology for mental health professionals [[electronic resource] /] / Jeffrey E. Kelsey, D. Jeffrey Newport, Charles B. Nemeroff |
| Autore | Kelsey Jeffrey E |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Liss, c2006 |
| Descrizione fisica | 1 online resource (411 p.) |
| Disciplina |
615.78
615/.78 |
| Altri autori (Persone) |
NewportD. Jeffrey
NemeroffCharles B |
| Soggetto topico |
Mental illness - Chemotherapy
Psychopharmacology |
| ISBN |
1-280-51752-2
9786610517527 0-470-30737-4 0-471-79463-5 0-471-79462-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
PRINCIPLES OF PSYCHOPHARMACOLOGY FOR MENTAL HEALTH PROFESSIONALS; CONTENTS; Preface; Faculty Disclosure; 1 INTRODUCTION AND OVERVIEW; Additional Reading; 2 BASICS OF PSYCHOPHARMACOLOGY; 2.1 Introduction; 2.1.1 Learning the Language of Pharmacology; 2.1.2 Overview; 2.2 Normal Human Nervous System; 2.2.1 Neuroanatomy: Structure of the Nervous System; 2.2.2 Neurophysiology: Function of the Nervous System; 2.3 Pathophysiology: Study of What Goes Wrong; 2.3.1 What Goes Wrong; 2.3.2 Why It Goes Wrong; 2.4 Pharmacology; 2.4.1 Introduction; 2.4.2 Pharmacokinetics; 2.4.3 Pharmacodynamics
2.4.4 Predicting Medication Effects2.4.5 Predicting Drug Interactions; 2.5 Putting It All Together; Additional Reading; 3 MOOD DISORDERS; 3.1 Introduction; 3.2 Major Depressive Disorder; 3.2.1 Brief Description and Diagnostic Criteria; 3.2.2 Prevalence and Risk Factors; 3.2.3 Presentation and Clinical Course; 3.2.4 Initial Evaluation and Differential Diagnosis; 3.2.5 History of Pharmacological Treatment; 3.2.6 Current Approach to Treatment; 3.2.7 Refractory Depression; 3.3 Dysthymic Disorder; 3.3.1 Brief Description and Diagnostic Criteria; 3.3.2 Prevalence and Risk Factors 3.3.3 Presentation and Clinical Course3.3.4 Initial Evaluation and Differential Diagnosis; 3.3.5 History of Pharmacological Treatment; 3.3.6 Current Approach to Treatment; 3.3.7 Refractory Depression; 3.4 Bipolar Disorders; 3.4.1 Brief Description and Diagnostic Criteria; 3.4.2 Prevalence and Risk Factors; 3.4.3 Presentation and Clinical Course; 3.4.4 Initial Evaluation and Differential Diagnosis; 3.4.5 History of Pharmacological Treatment; 3.4.6 Current Approach to Treatment; Additional Reading; 4 SCHIZOPHRENIA; 4.1 Brief Description and Diagnostic Criteria; 4.2 Prevalence and Risk Factors 4.3 Presentation and Clinical Course4.4 Initial Evaluation and Differential Diagnosis; 4.5 History of Treatment; 4.6 Current Approach to Treatment; 4.6.1 Prodromal Phase; 4.6.2 Acute Phase; 4.6.3 Maintenance Phase; 4.6.4 Residual Phase; 4.7 Treatment Resistant Schizophrenia; Additional Reading; 5 ANXIETY DISORDERS; 5.1 Introduction; 5.1.1 History of Anxiety Disorders; 5.1.2 Anxiety Symptoms; 5.1.3 Brief Overview of the Anxiety Disorders; 5.1.4 History of Pharmacological Treatment for Anxiety; 5.2 Panic Disorder; 5.2.1 Brief Description and Diagnostic Criteria 5.2.2 Prevalence and Risk Factors5.2.3 Presentation and Clinical Course; 5.2.4 Initial Evaluation and Differential Diagnosis; 5.2.5 History of Pharmacological Treatment; 5.2.6 Current Approach to Treatment; 5.3 Generalized Anxiety Disorder; 5.3.1 Brief Description and Diagnostic Criteria; 5.3.2 Prevalence and Risk Factors; 5.3.3 Presentation and Clinical Course; 5.3.4 Initial Evaluation and Differential Diagnosis; 5.3.5 History of Pharmacological Treatment; 5.3.6 Current Approach of Treatment; 5.4 Obsessive-Compulsive Disorder; 5.4.1 Brief Description and Diagnostic Criteria 5.4.2 Prevalence and Risk Factors |
| Record Nr. | UNINA-9910830140903321 |
|
Kelsey Jeffrey E
|
||
| Hoboken, N.J., : Wiley-Liss, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Principles of psychopharmacology for mental health professionals / / Jeffrey E. Kelsey, D. Jeffrey Newport, Charles B. Nemeroff
| Principles of psychopharmacology for mental health professionals / / Jeffrey E. Kelsey, D. Jeffrey Newport, Charles B. Nemeroff |
| Autore | Kelsey Jeffrey E |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Liss, c2006 |
| Descrizione fisica | 1 online resource (411 p.) |
| Disciplina | 615/.78 |
| Altri autori (Persone) |
NewportD. Jeffrey
NemeroffCharles B |
| Soggetto topico |
Mental illness - Chemotherapy
Psychopharmacology |
| ISBN |
1-280-51752-2
9786610517527 0-470-30737-4 0-471-79463-5 0-471-79462-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
PRINCIPLES OF PSYCHOPHARMACOLOGY FOR MENTAL HEALTH PROFESSIONALS; CONTENTS; Preface; Faculty Disclosure; 1 INTRODUCTION AND OVERVIEW; Additional Reading; 2 BASICS OF PSYCHOPHARMACOLOGY; 2.1 Introduction; 2.1.1 Learning the Language of Pharmacology; 2.1.2 Overview; 2.2 Normal Human Nervous System; 2.2.1 Neuroanatomy: Structure of the Nervous System; 2.2.2 Neurophysiology: Function of the Nervous System; 2.3 Pathophysiology: Study of What Goes Wrong; 2.3.1 What Goes Wrong; 2.3.2 Why It Goes Wrong; 2.4 Pharmacology; 2.4.1 Introduction; 2.4.2 Pharmacokinetics; 2.4.3 Pharmacodynamics
2.4.4 Predicting Medication Effects2.4.5 Predicting Drug Interactions; 2.5 Putting It All Together; Additional Reading; 3 MOOD DISORDERS; 3.1 Introduction; 3.2 Major Depressive Disorder; 3.2.1 Brief Description and Diagnostic Criteria; 3.2.2 Prevalence and Risk Factors; 3.2.3 Presentation and Clinical Course; 3.2.4 Initial Evaluation and Differential Diagnosis; 3.2.5 History of Pharmacological Treatment; 3.2.6 Current Approach to Treatment; 3.2.7 Refractory Depression; 3.3 Dysthymic Disorder; 3.3.1 Brief Description and Diagnostic Criteria; 3.3.2 Prevalence and Risk Factors 3.3.3 Presentation and Clinical Course3.3.4 Initial Evaluation and Differential Diagnosis; 3.3.5 History of Pharmacological Treatment; 3.3.6 Current Approach to Treatment; 3.3.7 Refractory Depression; 3.4 Bipolar Disorders; 3.4.1 Brief Description and Diagnostic Criteria; 3.4.2 Prevalence and Risk Factors; 3.4.3 Presentation and Clinical Course; 3.4.4 Initial Evaluation and Differential Diagnosis; 3.4.5 History of Pharmacological Treatment; 3.4.6 Current Approach to Treatment; Additional Reading; 4 SCHIZOPHRENIA; 4.1 Brief Description and Diagnostic Criteria; 4.2 Prevalence and Risk Factors 4.3 Presentation and Clinical Course4.4 Initial Evaluation and Differential Diagnosis; 4.5 History of Treatment; 4.6 Current Approach to Treatment; 4.6.1 Prodromal Phase; 4.6.2 Acute Phase; 4.6.3 Maintenance Phase; 4.6.4 Residual Phase; 4.7 Treatment Resistant Schizophrenia; Additional Reading; 5 ANXIETY DISORDERS; 5.1 Introduction; 5.1.1 History of Anxiety Disorders; 5.1.2 Anxiety Symptoms; 5.1.3 Brief Overview of the Anxiety Disorders; 5.1.4 History of Pharmacological Treatment for Anxiety; 5.2 Panic Disorder; 5.2.1 Brief Description and Diagnostic Criteria 5.2.2 Prevalence and Risk Factors5.2.3 Presentation and Clinical Course; 5.2.4 Initial Evaluation and Differential Diagnosis; 5.2.5 History of Pharmacological Treatment; 5.2.6 Current Approach to Treatment; 5.3 Generalized Anxiety Disorder; 5.3.1 Brief Description and Diagnostic Criteria; 5.3.2 Prevalence and Risk Factors; 5.3.3 Presentation and Clinical Course; 5.3.4 Initial Evaluation and Differential Diagnosis; 5.3.5 History of Pharmacological Treatment; 5.3.6 Current Approach of Treatment; 5.4 Obsessive-Compulsive Disorder; 5.4.1 Brief Description and Diagnostic Criteria 5.4.2 Prevalence and Risk Factors |
| Record Nr. | UNINA-9910876521003321 |
|
Kelsey Jeffrey E
|
||
| Hoboken, N.J., : Wiley-Liss, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||